FOXNews.com: Biocon, Bristol-Myers in deal for oral insulin drug

FOXNews.com FOX News Network - We Report. You Decide.

Biocon, Bristol-Myers in deal for oral insulin drug Nov 16th 2012, 12:40 Biocon Ltd, India's top-listed biotechnology company, said it signed an agreement with Bristol-Myers Squibb Co under which the U.S. drugmaker will have the option to get the worldwide license to its oral insulin drug program

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions